Year 2 Pharmacology Flashcards
amoxicillin
antibiotic
beta-lactam antibiotic
methicillin
antibiotic
transpeptidase inhibitor
cefuroxime
antibiotic
transpeptidase inhibitor
benzylpenicillin
antibiotic
transpeptidase inhibitor
oxytetracyline
antibiotic
30s inhibitor
erythromycin
antibiotic
50s inhibitor
gentamicin
antibiotic
30s/50s inhibitor
rifampicin
antibiotic
DNA dependent RNApol inhibitor
trimethoprim
antibiotic
folate antagonist
sulfamethoxazole
antibiotic
PABA analogue - competitively inhibit folic acid production
vancomycin
antibiotic
cell wall synthesis inhibitor
colistin
antibiotic phospholipid detergent (polymyxin)
ciprofloxacin
antibiotic
topoisomerase II inhibitor
fusidic acid
antibiotic
bacterial translation inhibitor
NSAIDs
analgesic
COX inhibitors
acyclovir
antiviral
DNApol inhibitor
amantadine
antiviral (also some antiparkinsonian effects)
ion channel disrupter - prevents uncoating
diamorphine
analgesic
mu-opioid agonist
amprenavir
antiviral
protease inhibitor
phenoxymethylpenicillin
antibiotic
transpeptidase inhibitor
zidovudine
antiviral
thymidine analogue - NRTI
clotrimazole
antifungal (antimycotic)
lanosterol 14-α-demethylase inhibitor - disrupts cell wall synthesis
fluconazole
antifungal (antimycotic)
lanosterol 14-α-demethylase inhibitor - disrupts cell wall synthesis
nystatin
antifungal (antimycotic)
binds to ergosterol to form cell wall pores
amphotericin
antifungal (antimycotic)
binds to ergosterol to form cell wall pores
pyrimethamine
antimalarial
folate antagonist
quinine
antimalarial
harm-polymerase inhibitor
artemether
antimalarial
reactive metabolite generator
clobetasone
corticosteroid
griseofulvin
antifungal (antimycotic)
mitosis inhibitor
dacarbazine
chemotherapy
alkylating agent
cyclophosphamide
chemotherapy
alkylating agent
rituximab
biologic cancer treatment (+ immunosuppression in autoimmune disease treatment)
chimeric (murine/human) anti-CD20 antibody mediates B cell lysis
doxorubicin
anthracycline chemotherapy agent
binds DNA to inhibit topoisomerase II
cell cycle non-specific
paclitaxel
taxoid chemotherapy agent
microtubule hyperstabilisation agent
cell cycle specific
tamoxifen
SERM
5-fluorouracil
chemotherapy
pyramidine analogue - inhibits DNA and RNA synthesis
cell cycle specific
etoposide
chemotherapy
inhibits DNA topoisomerase I I= errors in DNA synthesis and apoptosis
cell cycle specific: S and G2
vinblastine
vinca-alkaloid chemotherapy agent
tubular polymerase inhibitor = mitotic arrest
cell cycle specific: M
imatinib
biologic cancer treatment
BCR-Abl tyrosine kinase inhibitor
tretinoin
used for some dermatology conditions and for acute promyelocytic leukaemia (APL)
vitamin A analogue ?MoA
primaquine
quinolone derivative antimalarial
?MoA - site of action: liver
chloroquine
antimalarial (largely ineffective due to widespread resistant strains)
harm polymerase inhibitor
sit of action: blood
mefloquine
antimalarial
phospholipid interacting schizontocide
site of action: blood
doxycycline
antimalarial and antibiotic
tetracycline antibiotic
?antimalarial MoA - site of action: blood
malarone
atovaquone + proguanil
combination antimalarial therapy
atovaquone
antimalarial
inhibits electron transport chain = decreased ATP synthesis
site of action: liver
proguanil
antimalarial
inhibits parasitic reproductive enzyme dihydrofolate reductase
site of action: liver
enalapril / lisinopril / ramipril / captopril
antihypertensive
ACEi
amiloride
potassium sparing diuretic
sodium channel blocker